WP Leader: EAP

Duration: Months: 1-36
WP Partners: EAP   ViVI   EPA   THL   PRAKSIS   AIDFM   EUC   URZ   UBE

Objectives
Establish proactive partnerships with public health agencies to improve access to vaccination

• Evaluate the benefit of ImmuHub actions for public health
• Assess the impact of ImmuHub actions on vaccination uptake
• Integrate COVID-19 relevant technologies into public health strategy

WP 4 will be dedicated to concrete action to close immunisation gaps in difficult to reach or under- vaccinated populations in the European Region. To this end, we will be setting up 6 Innovative Immunisation Hubs (‘ImmuHubs’) in Cyprus, Finland, Greece, Poland, Portugal, and Serbia. Each country will set up hubs dedicated to three target populations in each country: In WP4, EAP/EPA will be assessing the impact of ImmuHubs Action on health literacy in the respective target populations. The impact of ImmuHubs Action on vaccine uptake will be analysed in  WP6